Walleye Trading
IPXL

Walleye Trading’s Impax Laboratories, Inc. IPXL Stock Holding History

Walleye Trading’s Portfolio IPXL Stock Details IPXL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-11,800
Closed -$190 – 4878
2017
Q2 		$190 Buy
+11,800
New +$174K ﹤0.01% 3152
2017
Q1 		– Sell
-43,700
Closed -$579K – 5408
2016
Q4 		$579K Buy
43,700
+40,885
+1,452% +$699K ﹤0.01% 1967
2016
Q3 		$67K Sell
2,815
-1,068
-28% -$28.7K ﹤0.01% 3575
2016
Q2 		$112K Buy
3,883
+1,545
+66% +$50.4K ﹤0.01% 3424
2016
Q1 		$75K Buy
+2,338
New +$82.2K ﹤0.01% 3582
2015
Q4 		– Sell
-15,222
Closed -$536K – 6006
2015
Q3 		$536K Buy
+15,222
New +$686K ﹤0.01% 1511

Other funds holding IPXL

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return
FI
Fosun International Hong Kong, China $399M AUM 16.11% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
FCM
Frontier Capital Management Boston, Massachusetts $9.73B AUM 55.65% 1-Year Est. Return

Walleye Trading's IPXL Position: Q3 2017 in Review

Walleye Trading sold out of Impax Laboratories, Inc. (IPXL) in Q3 2017, closing a stake of 11,800 shares — an estimated $190 sold.

Walleye Trading first reported a position in IPXL in Q3 2015 and held it in 6 quarters. The position peaked at $579K in Q4 2016. 189 funds tracked by Wall St. Rank hold IPXL as of Q3 2017.

  • Walleye Trading reported no remaining Impax Laboratories, Inc. position as of Q3 2017 after selling out during the quarter.
  • Walleye Trading sold 11,800 Impax Laboratories, Inc. shares in Q3 2017, an estimated $190.
  • Walleye Trading first reported a position in Impax Laboratories, Inc. in Q3 2015 and held it in 6 quarters.
  • Walleye Trading's Impax Laboratories, Inc. position peaked at $579K in Q4 2016.
  • 189 funds tracked by Wall St. Rank held Impax Laboratories, Inc. as of Q3 2017.

Based on Walleye Trading's 13F filing for Q3 2017, filed 14 Nov 2017.